Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Influenza A Virus Infection”

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT02247362
What this trial is testing

Study of Safety and Immunogenicity of a Quadrivalent Influenza Vaccine in Healthy Adults Age 65-75 Years

Who this might be right for
Influenza
VaxInnate Corporation 200
Testing effectiveness (Phase 2)Study completedNCT00867139
What this trial is testing

TCAD vs. Monotherapy for Influenza A in Immunocompromised Patients

Who this might be right for
Influenza
Fred Hutchinson Cancer Center 7
Post-approval studies (Phase 4)Study completedNCT00735475
What this trial is testing

Determine the Immunogenicity and Safety Profile of CSL Limited's Influenza Virus Vaccine Compared to a US Licensed Comparator Influenza Virus Vaccine

Who this might be right for
Influenza
Seqirus 1,268
Testing effectiveness (Phase 2)Study completedNCT00778895
What this trial is testing

Clinical Study in Children, 6 Months to 3 Years of Age, to Assess Two Dose Levels of an Experimental Flu Vaccine, Using a Licensed Influenza Virus Vaccine, Vaxigrip® as the Control

Who this might be right for
Influenza
GlaxoSmithKline 390
Early research (Phase 1)Study completedNCT00973895
What this trial is testing

VRC 308: An Open-Label Phase I Study of the Safety and Immunogenicity of an Investigational H1 DNA Influenza Vaccine, VRC-FLUDNA057-00-VP, in Healthy Adults 18-70 Years Old

Who this might be right for
Influenza A Virus, H1N1 SubtypeNovel Swine-Origin
National Institute of Allergy and Infectious Diseases (NIAID) 20
Not applicableStudy completedNCT04723771
What this trial is testing

Influenza Vaccine Effectiveness of a Quadrivalent Vaccine in Pregnant Women and Young Infants, 2019-2020

Who this might be right for
Influenza in Human
University of Athens 949
Not applicableStudy completedNCT06191393
What this trial is testing

SARS-CoV-2 and Influenza A/B in Point-of-Care and Non-Laboratory Settings

Who this might be right for
SARS-CoV-2 InfectionInfluenza AInfluenza B
Aptitude Medical Systems 614
Testing effectiveness (Phase 2)Study completedNCT02307851
What this trial is testing

Quadrivalent Influenza VLP Vaccine Dose Ranging Study in Young Adults

Who this might be right for
Influenza
Novavax 400
Testing effectiveness (Phase 2)Study completedNCT06695130
What this trial is testing

Study of a Combination Vaccine Comprised of Different Recombinant Spike Antigen Levels of a Matrix-M Adjuvanted Recombinant COVID-19 Vaccine and Recombinant Influenza Vaccine in Adult Participants 50 Years of Age and Older

Who this might be right for
COVID-19 ImmunizationInfluenza Immunization
Sanofi 980
Post-approval studies (Phase 4)Active Not RecruitingNCT07232745
What this trial is testing

Mucosal and Systemic Immune Responses Induced by an Intranasal Influenza Live Attenuated Vaccine

Who this might be right for
Influenza
Jiangsu Province Centers for Disease Control and Prevention 60
Testing effectiveness (Phase 2)Study completedNCT00306995
What this trial is testing

Safety Study of Pandemic Candidate Influenza Vaccines in the Elderly Population

Who this might be right for
InfluenzaInfluenza Vaccines
GlaxoSmithKline 385
Large-scale testing (Phase 3)Study completedNCT00128167
What this trial is testing

Trivalent, Live, Cold Adapted Influenza Vaccine (CAIV-T) Against Inactivated Influenza Vaccine (TIV) in Children 6-59 Months of Age

Who this might be right for
Influenza
MedImmune LLC 8,500
Early research (Phase 1)UnknownNCT02015494
What this trial is testing

Phase 1 Safety Study of Recombinant Influenza Vaccine for Prevention

Who this might be right for
Influenza
VaxInnate Corporation 316
Early research (Phase 1)Study completedNCT01258530
What this trial is testing

Evaluate the Bioequivalence of Over-encapsulated Oseltamivir Capsules to Marketed Oseltamivir Capsules in Healthy Volunteers

Who this might be right for
Influenza, Human
GlaxoSmithKline 28
Early research (Phase 1)Study completedNCT01609998
What this trial is testing

Seasonal Influenza DNA Vaccine & Seasonal Influenza Trivalent Inactivated Vaccine (TIV) in Children & Adolescents

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 75
Post-approval studies (Phase 4)Study completedNCT00873912
What this trial is testing

A Prospective Study to Evaluate the Safety of a New Monovalent Intranasal Influenza Vaccine

Who this might be right for
Healthy
MedImmune LLC 300
Testing effectiveness (Phase 2)Study completedNCT00461981
What this trial is testing

Evaluate Immune Responses of FluMist®

Who this might be right for
Influenza Vaccine
MedImmune LLC 101
Testing effectiveness (Phase 2)Study completedNCT00952419
What this trial is testing

Different Formulations of an A/H1N1 Pandemic Vaccine in Healthy Children Aged 6 Months to 9 Years

Who this might be right for
InfluenzaSwine-origin A/H1N1 Influenza
Sanofi Pasteur, a Sanofi Company 474
Early research (Phase 1)Looking for participantsNCT06355232
What this trial is testing

Covid-19 and Influenza Oral Vaccine Study

Who this might be right for
covid19 InfectionInfluenza, Human
Vaxine Pty Ltd 100
Post-approval studies (Phase 4)Study completedNCT01104493
What this trial is testing

A Clinical Study to Assess the Safety of a New Influenza Vaccine

Who this might be right for
Healthy
MedImmune LLC 300
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation